Kazakova I.A., Ievlev Y.N.
Electrophoretic mobility of erythrocytes in patients with chronic renal disease of 5th dialysis stage with different level of arterial pressure
|
№2 / 2019
|
Ievlev Y.N., Kazakova I.A.
Sexual function as a quality of life parameter of patients with chronic kidney disease (stage 5) and arterial hypertension
|
№2 / 2019
|
Mamedguseinova S.S., Kokorin V.A., Gordeev I.G.
Current opportunities of device-based treatment of arterial hypertension
|
№1 / 2019
|
Shulutko B.I., Makarenko S.V.
About comorbidity, entity of pathogenesis and optimization of internal diseases therapy
|
№1 / 2019
|
A.G. Evdokimova, E.V. Kovalenko, V.V. Evdokimov, K.I. Tebloev
The efficacy of angiotensin II receptors’ blockers use in patients wkth arterial hypertension and metabolic syndrome
|
№4 / 2018
|
S.N. Tolpygina
Possibility of high-selective adrenoblockers use in combined therapy ofpatients with metabolic syndrome
|
№4 / 2018
|
L.A. Andreeva, L.A. Panchenkova, A.I. Martynov, E.A. Troshina, K.A. Khamidova, E.E. Kazanceva, L.A. Medvedeva, G.G. Karnuta, T.E. Yurkova
Dayly dynamics of indices of central aortic pressure and arterial stiffness in patients with arterial hypertension in the composition of a metabolic syndrome at the background of a fixed-dose combination of perindopril arginine and indapamide
|
№1 / 2018
|
Yu.V. Lukina
The advantages of using fixed combinations of antihypertensive drugs in clinical practice
|
№8 / 2017
|
N.P. Lyamina, A.V. Nalivaeva
Rational therapy of hypertensive crisis in the light of modern recommendations
|
№6 / 2017
|
S.N. Mammayev, KH.I. Ibragimova
Influence of antihypertensive therapy at endotheline-1 level in arterial hypertensive patients
|
№6 / 2017
|
A.G. Evdokimova, Е.V. Коvаlеnко, V.V. Evdokimov, К.I. Теblоеv, I.А. Shvetsova
Features of use of angiotensin receptor blockers in clinical practice (focus on candesartan)
|
№6 / 2017
|
G.A. Batishcheva, O.A. Mubarakshina, M.N. Somova, A.S. Yevstigneeva
Possibilities of fixed combination of nitrendipine and enalapril in the treatment of arterial hypertension
|
№6 / 2017
|